$Foghorn Therapeutics (FHTX.US)$Reuters· 2 mins ago Foghorn Therapeutics Inc. - Phase 1 Trial of Fhd-286 Showed Clinical Responses but Did Not Meet Threshold
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
3
Translate
Report
2126 Views
Comment
Sign in to post a comment
Daily Investors
:
Hey I started a Bio Tech group, I know your on the same exact thing. If you want in you can. It is only for Bio and Major Pharm. But just what iv put in their over the weekend and today. Def worth it, if you want in send me a FR and I'll add you in
Daily Investors
:
* Editas Medicine laid off 65% of its workforce after failing to find a partner for its reni-cel program. * Medtronic's latest PillCam completed its first patient procedure. * AbbVie acquired oral peptide biotech Nimble for $200 million. * Novartis paid PTC $1 billi...
Trytosaveabit
OPDaily Investors
:
Thank you! I’ll have to think it over. I’m so busy already that I’m not sure if I’ll be able to contribute much! But again thank you
Daily Investors : Hey I started a Bio Tech group, I know your on the same exact thing. If you want in you can. It is only for Bio and Major Pharm. But just what iv put in their over the weekend and today. Def worth it, if you want in send me a FR and I'll add you in
Daily Investors : * Editas Medicine laid off 65% of its workforce after failing to find a partner for its reni-cel program.
* Medtronic's latest PillCam completed its first patient procedure.
* AbbVie acquired oral peptide biotech Nimble for $200 million.
* Novartis paid PTC $1 billi...
Trytosaveabit OP Daily Investors : Thank you! I’ll have to think it over. I’m so busy already that I’m not sure if I’ll be able to contribute much! But again thank you